Microparticles stimulate the synthesis of prostaglandin E(2) via induction of cyclooxygenase 2 and microsomal prostaglandin E synthase 1.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Arthritis & Rheumatism

• Publication date

  2007-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ART.22980PMID 17968936
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Signal pathways involved in the regulation of prostaglandin E synthase-1 in human gingival fibroblasts.

  2006cited by this paper
• c-Jun N-terminal Kinase-mediated Stabilization of Microsomal Prostaglandin E2 Synthase-1 mRNA Regulates Delayed Microsomal Prostaglandin E2 Synthase-1 Expression and Prostaglandin E2 Biosynthesis by Cardiomyocytes*

  2006cited by this paper
• TGF-β1 induces COX-2 expression and PGE2 synthesis through MAPK and PI3K pathways in human mesangial cells

  2006cited by this paper
• Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells.

  2006cited by this paper
• TGF-beta1 induces COX-2 expression and PGE2 synthesis through MAPK and PI3K pathways in human mesangial cells.

  2006cited by this paper
• Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases.

  2005cited by this paper
• The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles.

  2005cited by this paper
• Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis.

  2005cited by this paper
• Curcumin Suppresses Interleukin 1β-Mediated Microsomal Prostaglandin E Synthase 1 by Altering Early Growth Response Gene 1 and Other Signaling Pathways

  2005cited by this paper
• Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis.

  2004cited by this paper
• mPGES-1 as a novel target for arthritis

  2004cited by this paper
• Bucillamine induces the synthesis of vascular endothelial growth factor dose-dependently in systemic sclerosis fibroblasts via nuclear factor-kappaB and simian virus 40 promoter factor 1 pathways.

  2004cited by this paper
• Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts.

  2003cited by this paper
• Evolving concepts of rheumatoid arthritis

  2003cited by this paper
• Contribution of membrane‐associated prostaglandin E2 synthase to bone resorption

  2003cited by this paper
• Human Microsomal Prostaglandin E Synthase-1

  2003cited by this paper
• Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism.

  2002cited by this paper
• Phospholipid composition of cell-derived microparticles determined by one-dimensional high-performance thin-layer chromatography.

  2002cited by this paper
• Molecular Identification of Cytosolic Prostaglandin E2 Synthase That Is Functionally Coupled with Cyclooxygenase-1 in Immediate Prostaglandin E2Biosynthesis*

  2000cited by this paper
• Fibroblast biology: Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis

  2000cited by this paper
• Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target.

  1999cited by this paper
• The role of COX-2 produced by cartilage in arthritis.

  1999cited by this paper
• In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant.

  1999cited by this paper
• Pharmacological analysis of cyclooxygenase-1 in inflammation.

  1998cited by this paper
• Increased expression of human type IIa secretory phospholipase A2 antigen in arthritic synovium

  1998cited by this paper
• Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases.

  1998cited by this paper
• The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection.

  1997cited by this paper
• Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin‐1: a potential mechanism for inflammatory angiogenesis

  1995cited by this paper
• Specific suppression by prostaglandin E2 of activation-induced apoptosis of human CD4+CD8+ T lymphoblasts.

  1995cited by this paper
• Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.

  1994cited by this paper
• NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions.

  1993cited by this paper
• A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells.

  1991cited by this paper
• Revised criteria for the classification of rheumatoid arthritis.

  1990cited by this paper
• The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

  1988cited by this paper
• Immunohistochemical localization of prostaglandin E in rheumatoid synovial tissues.

  1977cited by this paper

• Novel perspectives on extracellular vesicles in autoimmune diseases: immunogenicity, inflammation, and immune surveillance

  2026cites this paper
• Reprogramming of the inflammatory microenvironment by a therapeutic compound from Alangium chinense (Lour.) harms via dual modulation of COX-2 and autophagy in rheumatoid arthritis.

  2026cites this paper
• Two Sides of the Same Coin—Mechanistic Insight, Diagnostic Application and Therapeutic Translation of Bacterial and Host‐Derived Extracellular Vesicles

  2025cites this paper
• Epi-revolution in rheumatology: the potential of histone deacetylase inhibitors for targeted rheumatoid arthritis intervention

  2024cites this paper
• Updates on the Pathophysiology and Therapeutic Potential of Extracellular Vesicles with Focus on Exosomes in Rheumatoid Arthritis

  2024cites this paper
• Total lignans from Vitex negundo seeds attenuate osteoarthritis and their main component vitedoin A alleviates osteoclast differentiation by suppressing ERK/NFATc1 signaling

  2023cites this paper
• Proteomics profiling of CD4 + T-cell-derived exosomes from patients with rheumatoid arthritis.

  2023cites this paper
• Equine osteoarthritis modifies fatty acid signatures in synovial fluid and its extracellular vesicles

  2023cites this paper
• Exosomal long non-coding RNA TRAFD1-4:1 derived from fibroblast-like synoviocytes suppresses chondrocyte proliferation and migration by degrading cartilage extracellular matrix in rheumatoid arthritis.

  2022cites this paper
• RA Fibroblast-Like Synoviocytes Derived Extracellular Vesicles Promote Angiogenesis by miRNA-1972 Targeting p53/mTOR Signaling in Vascular Endotheliocyte

  2022cites this paper
• Fatty Acids and Oxylipins in Osteoarthritis and Rheumatoid Arthritis—a Complex Field with Significant Potential for Future Treatments

  2021cites this paper
• Exosome: Function and Application in Inflammatory Bone Diseases

  2021cites this paper
• The role of extracellular vesicles in rheumatoid arthritis: a systematic review

  2021cites this paper
• Extracellular Vesicles in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Functions and Applications

  2021cites this paper
• Circulating extracellular vesicles and rheumatoid arthritis: a proteomic analysis

  2021cites this paper
• Extracellular Vesicles and Their Potential Significance in the Pathogenesis and Treatment of Osteoarthritis

  2021cites this paper
• Chicken‐or‐egg question: Which came first, extracellular vesicles or autoimmune diseases?

  2020cites this paper
• Epigenetics in osteoarthritis: Novel spotlight

  2019cites this paper
• Extracellular vesicles in biological fluids. A biomarker of exposure to cigarette smoke and treatment with chemopreventive drugs

  2019cites this paper
• Characterization of cell-derived microparticles in synovial fluid and plasma of patients with rheumatoid arthritis

  2019cites this paper
• Circulating microparticles in septic shock and sepsis-related complications.

  2019cites this paper
• Extracellular vesicle-associated MMPs: A modulator of the tissue microenvironment.

  2019cites this paper
• Extracellular Vesicles in Joint Disease and Therapy

  2018cites this paper
• Large Extracellular Vesicles: Have We Found the Holy Grail of Inflammation?

  2018cites this paper
• A systematic review on the role of eicosanoid pathways in rheumatoid arthritis.

  2018cites this paper
• From blood coagulation to innate and adaptive immunity: the role of platelets in the physiology and pathology of autoimmune disorders

  2018cites this paper
• TLR3 Ligand Poly(I:C) Exerts Distinct Actions in Synovial Fibroblasts When Delivered by Extracellular Vesicles

  2018cites this paper
• Role of extracellular vesicles in rheumatoid arthritis

  2018cites this paper
• Synovial fibroblasts in 2017

  2017cites this paper
• Microvesicles in vascular homeostasis and diseases

  2017cites this paper
• Suppressing mPGES‐1 expression by sinomenine ameliorates inflammation and arthritis

  2017cites this paper
• Pathogenic or Therapeutic Extracellular Vesicles in Rheumatic Diseases: Role of Mesenchymal Stem Cell-Derived Vesicles

  2017cites this paper
• Pomegranate extract alleviates disease activity and some blood biomarkers of inflammation and oxidative stress in Rheumatoid Arthritis patients

  2017cites this paper
• Microsomal Prostaglandin E Synthase-1 Expression in Inflammatory Conditions Is Downregulated by Dexamethasone: Seminal Role of the Regulatory Phosphatase MKP-1

  2017cites this paper
• PDE4 inhibitor rolipram inhibits the expression of microsomal prostaglandin E synthase‐1 by a mechanism dependent on MAP kinase phosphatase‐1

  2017cites this paper
• Short-term particulate matter exposure induces extracellular vesicle release in overweight subjects

  2017cites this paper
• Elucidating the metabolism of n-3 polyunsaturated fatty acids and formation of bioactive lipid mediators in human skin

  2017cites this paper
• Extracellular vesicles are integral and functional components of the extracellular matrix.

  2017cites this paper
• Extracellular vesicles are present in mouse lymph and their level differs in atherosclerosis

  2016cites this paper
• The Role of Microparticles in Rheumatic Diseases and their Potentials as Therapeutic Tools

  2016cites this paper
• First in vivo detection and characterization of hyaluronan‐coated extracellular vesicles in human synovial fluid

  2016cites this paper
• Extracellular vesicles in the pathogenesis of rheumatoid arthritis and osteoarthritis

  2016cites this paper
• Deletion of mPGES-1 affects platelet functions in mice.

  2016cites this paper
• Extracellular vesicles — new tool for joint repair and regeneration

  2016cites this paper
• Microparticles That Form Immune Complexes as Modulatory Structures in Autoimmune Responses

  2015cites this paper
• Extracellular Vesicles: Evolving Contributors in Autoimmunity.

  2015cites this paper
• Neutrophil derived microvesicles: emerging role of a key mediator to the immune response.

  2014cites this paper
• Endothelial and cancer cells interact with mesenchymal stem cells via both microparticles and secreted factors

  2014cites this paper
• Extracellular Vesicles in Cardiovascular Disease

  2014cites this paper
• Persisting eicosanoid pathways in rheumatic diseases

  2014cites this paper
• Emerging role of extracellular vesicles in inflammatory diseases

  2014cites this paper
• The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis

  2013cites this paper
• Extracellular Thimet Oligopeptidase is Carried by Cell Membrane Microvesicles of Human Prostate Cancer Cells

  2013cites this paper
• Classification, Functions, and Clinical Relevance of Extracellular Vesicles

  2012cites this paper
• Microparticles as mediators and biomarkers of rheumatic disease.

  2012cites this paper
• Immune cell-derived vesicles: modulators and mediators of inflammation.

  2012cites this paper
• Microparticles from stored red blood cells activate neutrophils and cause lung injury after hemorrhage and resuscitation.

  2012cites this paper
• Induction of apoptosis in circulating angiogenic cells by microparticles.

  2011cites this paper
• Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis

  2011influential citation
• Microparticles, Vascular Function, and Atherothrombosis

  2011cites this paper
• The role of epigenetics in immune disorders

  2011cites this paper
• Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway

  2011cites this paper
• Inhibition of inflammatory mediators and related signaling pathways by macrophage-stimulating protein in rheumatoid arthritis synovial fibroblasts

  2011influential citation
• Platelet-derived serotonin links vascular disease and tissue fibrosis

  2011influential citation
• Microparticles from apoptotic monocytes enhance nitrosative stress in human endothelial cells

  2011cites this paper
• The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.

  2010cites this paper
• Microparticles in physiological and in pathological conditions

  2010cites this paper
• Pharmacological modulation and manipulation of cancer drug resistance

  2010cites this paper
• The role of microparticles in the pathogenesis of rheumatic diseases

  2010cites this paper
• Microparticles stimulate angiogenesis by inducing ELR+ CXC-chemokines in synovial fibroblasts

  2010cites this paper
• Proteomic analysis identification of a pattern of shared alterations in the secretome of dermal fibroblasts from systemic sclerosis and nephrogenic systemic fibrosis.

  2010cites this paper
• Inflammation: Microparticles and their roles in inflammatory arthritides

  2010cites this paper
• Microparticles and inflammatory joint disease.

  2010cites this paper
• Microparticles as autoadjuvants in the pathogenesis of SLE

  2010cites this paper
• Microsomal Prostaglandin E Synthase-1 in Rheumatic Diseases

  2010cites this paper
• Microparticules et rhumatismes inflammatoires

  2010cites this paper
• Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis.

  2009cites this paper
• Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity

  2009cites this paper
• Inhibitor of DNA binding/differentiation 2 induced by hypoxia promotes synovial fibroblast-dependent osteoclastogenesis.

  2009cites this paper
• Stiff skin syndrome: evidence for an inflammation-independent fibrosis?

  2009cites this paper
• Microparticle-induced release of B-lymphocyte regulators by rheumatoid synoviocytes

  2009cites this paper
• Innate immunity, epigenetics and autoimmunity in rheumatoid arthritis.

  2009cites this paper
• Molecular mechanisms of fibroblast activation in the pathogenesis of systemic sclerosis

  2009cites this paper
• Up-regulation of cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic cells by macrophage migration inhibitory factor: involvement of novel kinase signaling pathways.

  2009cites this paper
• Transcription Factor Fos-Related Antigen-2 Induces Progressive Peripheral Vasculopathy in Mice Closely Resembling Human Systemic Sclerosis

  2009cites this paper
• Rho-associated kinases are crucial for myofibroblast differentiation and production of extracellular matrix in scleroderma fibroblasts.

  2008cites this paper